The arthritis drug tocilizumab has been shown to reduce deaths among patients hospitalized with severe COVID-19 in a new study.
In the trial, 2,022 hospitalized COVID-19 patients received tocilizumab, while 2,094 patients received usual care; in the former group, 29 percent of patients died within 28 days, while 33 percent of patients died within 28 days in the latter group, BBC News reports. Eighty-two percent of patients were taking a systemic steroid like dexamethasone in the trial.
"This means that for every 25 patients treated with tocilizumab, one additional life would be saved," a news release said.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Additionally, tocilizumab was shown to shorten the amount of time until patients are discharged from the hospital, as well as reduce the need for them to go on a mechanical ventilator, researchers said. The trial's joint chief investigator, Martin Landray, said that the results "clearly show the benefits of tocilizumab and dexamethasone in tackling the worst consequences of COVID-19 — improving survival, shortening hospital stay, and reducing the need for mechanical ventilators." Landray added that "used in combination, the impact is substantial."
-
When does autumn begin?The Explainer The UK is experiencing a 'false autumn', as climate change shifts seasonal weather patterns
-
The rise of the performative maleTalking Point What the latest internet trope tells us about gender roles, dating and male illiteracy
-
5 cracking cartoons about the new Cracker Barrel logoCartoons Artists take on MAGA designs, real issues, and more
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
